Clinical Trials
Currently we are performing clinical investigations of novel CAR-T and TIL therapies in multiple disease areas including hematological malignancies, solid tumors and inflammatory and immunological diseases.
| Product | Indication | Clinical Study | NCT NUMBER(s) | PUBLICATION/PRESENTATION |
|---|---|---|---|---|
| C-CAR031 | Hepatocellular Carcinoma (HCC) | Phase I/II trial in China | NCT06590246 | AACR Abstract 04/2023 AACR Poster 04/2023 |
| C-CAR039 | r/r B-NHL | Investigator-initiated trial in China | NCT04317885 | |
| NCT04655677 | ||||
| NCT04696432 | ||||
| NCT04693676 | ||||
| Phase 1b/2 trial in China | NCT05800977 | |||
| Phase 1b trial worldwide (ex-Greater China) licensed to JNJ | NCT05421663 | |||
| C-CAR066 | r/r B-NHL including prior CAR-T | Investigator-initiated trial in China | NCT04036019 | |
| Phase 1b trial worldwide (ex-Greater China) licensed to JNJ | NCT05784441 | |||
| C-CAR168 | Autoimmune Diseases (Lupus Nephritis and SLE) | Investigator-initiated trial in China | NCT06249438 | ACR Convergence 2024 Presentation |